The thick client is making a comeback. Here’s how next-generation local databases like PGlite and RxDB are bringing ...

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

While little is known about what the large-scale data center will be used for at this point, here’s a closer look at what we do know.

Glimmers of a resurgence in biotech IPO activity in 2026 have continued with the news that two more companies – Belgium's AgomAb Therapeutics and SpyGlass Pharma of the US – are sizing up investor ...

Ascendis wins US approval for therapy for children with dwarfism The U.S. Food and Drug Administration on Friday approved Ascendis Pharma's once-weekly therapy for children with a rare genetic ...